<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">101718325</journal-id><journal-id journal-id-type="pubmed-jr-id">47137</journal-id><journal-id journal-id-type="nlm-ta">JMIR Cardio</journal-id><journal-id journal-id-type="iso-abbrev">JMIR Cardio</journal-id><journal-title-group><journal-title>JMIR cardio</journal-title></journal-title-group><issn pub-type="epub">2561-1011</issn></journal-meta><article-meta><article-id pub-id-type="pmid">29473644</article-id><article-id pub-id-type="pmc">5818980</article-id><article-id pub-id-type="doi">10.2196/cardio.8543</article-id><article-id pub-id-type="manuscript">HRAMS927354</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The Atrial Fibrillation Health Literacy Information Technology
System: Pilot Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Magnani</surname><given-names>Jared W</given-names></name><degrees>MSc, MD</degrees><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Schlusser</surname><given-names>Courtney L</given-names></name><degrees>BA</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kimani</surname><given-names>Everlyne</given-names></name><degrees>BSc</degrees><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Rollman</surname><given-names>Bruce L</given-names></name><degrees>MPH, MD</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Paasche-Orlow</surname><given-names>Michael K</given-names></name><degrees>MA, MPH, MD</degrees><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Bickmore</surname><given-names>Timothy W</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="A3">3</xref></contrib></contrib-group><aff id="A1">
<label>1</label>Division of Cardiology, Department of Medicine, UPMC Heart and
Vascular Institute, University of Pittsburgh, Pittsburgh, PA, United States</aff><aff id="A2">
<label>2</label>Center for Behavioral Health Smart Technology, Department of
Medicine, University of Pittsburgh, Pittsburgh, PA, United States</aff><aff id="A3">
<label>3</label>College of Computer and Information Science, Northeastern
University, Boston, MA, United States</aff><aff id="A4">
<label>4</label>Section of General Internal Medicine, Department of Medicine, Boston
University, Boston, MA, United States</aff><author-notes><corresp id="FN1"><bold>Corresponding Author:</bold> Jared W Magnani, MSc, MD,
Division of Cardiology, Department of Medicine, UPMC Heart and Vascular
Institute, University of Pittsburgh, UPMC Presbyterian Hospital, Suite 5-B, 200
Lothrop Street, Pittsburgh, PA, 15213, United States, Phone: 1 412 648 6920,
Fax: 1 412 802 6395, <email>magnanij@pitt.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>21</day><month>12</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>12</day><month>12</month><year>2017</year></pub-date><pub-date pub-type="ppub"><season>Jul-Dec</season><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>20</day><month>2</month><year>2018</year></pub-date><volume>1</volume><issue>2</issue><elocation-id>e7</elocation-id><permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p><!--CREATIVE COMMONS-->This is an open-access article distributed under the terms of the
Creative Commons Attribution License
(<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted
use, distribution, and reproduction in any medium, provided the original
work, first published in JMIR Cardio, is properly cited. The complete
bibliographic information, a link to the original publication on
<ext-link ext-link-type="uri" xlink:href="http://cardio.jmir.org,">http://cardio.jmir.org,</ext-link> as well as this copyright and license information
must be included.</license-p></license></permissions><self-uri xlink:href="http://cardio.jmir.org/2017/2/e7/"/><abstract><sec id="S1"><title>Background</title><p id="P1">Atrial fibrillation (AF) is a highly prevalent heart rhythm condition
that has significant associated morbidity and requires chronic treatment.
Mobile health (mHealth) technologies have the potential to enhance multiple
aspects of AF care, including education, monitoring of symptoms, and
encouraging and tracking medication adherence. We have previously
implemented and tested relational agents to improve outcomes in chronic
disease and sought to develop a smartphone-based relational agent for
improving patient-centered outcomes in AF.</p></sec><sec id="S2"><title>Objective</title><p id="P2">The objective of this study was to pilot a smartphone-based
relational agent as preparation for a randomized clinical trial, the Atrial
Fibrillation Health Literacy Information Technology Trial (AF-LITT).</p></sec><sec id="S3"><title>Methods</title><p id="P3">We developed the relational agent for use by a smartphone consistent
with our prior approaches. We programmed the relational agent as a
computer-animated agent to simulate a face-to-face conversation and to serve
as a health counselor or coach specific to AF. Relational agent&#x02019;s
dialogue content, informed by a review of literature, focused on
patient-centered domains and qualitative interviews with patients with AF,
encompassed AF education, common symptoms, adherence challenges, and patient
activation. We established that the content was accessible to individuals
with limited health or computer literacy. Relational agent content
coordinated with use of the smartphone AliveCor Kardia heart rate and rhythm
monitor. Participants (N=31) were recruited as a convenience cohort
from ambulatory clinical sites and instructed to use the relational agent
and Kardia for 30 days. We collected demographic, social, and clinical
characteristics and conducted baseline and 30-day assessments of
health-related quality of life (HRQoL) with the Atrial Fibrillation Effect
on Quality of life (AFEQT) measure; self-reported medication adherence with
the Morisky 8-item Medication Adherence Scale (MMAS-8); and patient
activation with the Patient Activation Measure (PAM).</p></sec><sec id="S4"><title>Results</title><p id="P4">Participants (mean age 68 [SD 11]; 39%
[12/31] women) used the relational agent for an average 17.8
(SD 10.0) days. The mean number of independent log-ins was 19.6 (SD 10.7),
with a median of 20 times over 30 days. The mean number of Kardia uses was
26.5 (SD 5.9), and participants using Kardia were in AF for 14.3 (SD 11.0)
days. AFEQT scores improved significantly from 64.5 (SD 22.9) at baseline to
76.3 (SD 19.4) units at 30 days (<italic>P</italic>&#x0003c;.01). We
observed marginal but statistically significant improvement in self-reported
medication adherence (baseline: 7.3 [SD 0.9], 30 days: 7.7
[SD 0.5]; <italic>P</italic>=.01). Assessments of
acceptability identified that most of the participants found the relational
agent useful, informative, and trustworthy.</p></sec><sec id="S5"><title>Conclusions</title><p id="P5">We piloted a 30-day smartphone-based intervention that combined a
relational agent with dedicated content for AF alongside Kardia heart rate
and rhythm monitoring. Pilot participants had favorable improvements in
HRQoL and self-reported medication adherence, as well as positive responses
to the intervention. These data will guide a larger, enhanced randomized
trial implementing the smartphone relational agent and the Kardia monitor
system.</p></sec></abstract><kwd-group><kwd>atrial fibrillation</kwd><kwd>mHealth</kwd><kwd>health-related quality of life</kwd><kwd>medication adherence</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="S6"><title>Introduction</title><p id="P6">Atrial fibrillation (AF) is a chronic and highly prevalent heart rhythm
condition [<xref rid="R1" ref-type="bibr">1</xref>]. Treatment for
AF requires long-term adherence to complex therapies that include anticoagulants and
medications for heart rate and rhythm control [<xref rid="R2" ref-type="bibr">2</xref>]. AF has variable symptoms that fluctuate in
severity and is associated with increased risks of adverse outcomes such as heart
failure, stroke, hospitalization, and mortality [<xref rid="R3" ref-type="bibr">3</xref>]. The diverse treatments, symptoms, and
potential for adverse outcomes combine to make AF a challenging condition for
patients, which is associated with poor health-related quality of life (HRQoL)
[<xref rid="R4" ref-type="bibr">4</xref>&#x02013;<xref rid="R6" ref-type="bibr">6</xref>]. AF professional guidelines prioritize routine
symptom assessment and monitoring to guide the treatment course [<xref rid="R2" ref-type="bibr">2</xref>]. Patients may have varying access to
care, which may be further compromised by challenges to health literacy and
obstacles to medication adherence [<xref rid="R7" ref-type="bibr">7</xref>]. Similarly, intermittent visits are the standard for clinical
care, and patients may experience problems related to this chronic, complex disease
between such visits.</p><p id="P7">Mobile health (mHealth) technologies have the potential to enhance multiple
aspects of patient care by providing education, monitoring, of symptoms, and
encouraging and tracking adherence to long-term pharmacological therapies or
behaviors. We have developed and used relational agents in prior contexts to augment
patient-centered health care. The relational agent is an animated character that
provides health education, monitoring, and problem solving with speech, facial
expression, and body gestures. Users converse and respond with on-screen selections,
which in turn activate further dialogue with the agent. <xref rid="F1" ref-type="fig">Figure 1</xref> shows screenshots of the relational eliciting
symptoms pertinent to AF and gesturing to enhance educational content. We propose
the relational agent as a vehicle for improving chronic disease self-management,
which provides practical strategies to negotiate the long-term self-care and
medication adherence that are essential for patient&#x02019;s success with a chronic
disease such as AF [<xref rid="R8" ref-type="bibr">8</xref>].</p><p id="P8">Our prior work has demonstrated that a relational agent is an effective
health educator for all levels of health literacy and improves self-management and
HRQoL [<xref rid="R9" ref-type="bibr">9</xref>&#x02013;<xref rid="R13" ref-type="bibr">13</xref>]. In randomized studies, we have demonstrated
that the use of the relational agent improves pharmacological adherence, diet, and
physical activity, and it reduces the likelihood of hospital readmission
[<xref rid="R14" ref-type="bibr">14</xref>&#x02013;<xref rid="R16" ref-type="bibr">16</xref>]. Specific examples of our application of the
relational agent to improve adherence include a clinical trial with 263 older adults
to increase adherence over 12 months of routine physical activity [<xref rid="R17" ref-type="bibr">17</xref>] and the promotion of adherence to
antipsychotic medication in schizophrenia (n=20) [<xref rid="R18" ref-type="bibr">18</xref>]. In an additional larger application, we
examined the effect of the relational agent to improve communication with patients
at hospital discharge (N=764) and found that the agent was associated with
reduced rates of readmission and improved patient satisfaction [<xref rid="R19" ref-type="bibr">19</xref>]. The relational agent is a
multifaceted intervention. It serves as a nonjudgmental empathetic coach and
educator to provide patient-centered guidance.</p><p id="P9">To our knowledge, relational agents have had limited application in
cardiovascular disease and have not been used in AF previously. Current ambulatory
monitoring in AF focuses predominantly on AF detection [<xref rid="R20" ref-type="bibr">20</xref>&#x02013;<xref rid="R22" ref-type="bibr">22</xref>]. Although such efforts have a clinical application, they may not
provide patient-centered health coaching. The relational agent, in contrast, can
assist patients to develop essential skills to understand monitoring results and
respond to them.</p><p id="P10">Relational agents may be combined with other mHealth technology to augment
their health-related impact. The AliveCor Kardia mobile heart rhythm monitor
(AliveCor, Inc, Mountain View, CA) or Kardia for simplicity, allows individuals to
monitor heart rate and rhythm with the help of a smartphone with results being
uploaded for centralized review. Kardia has been used prospectively in various
studies, again principally for AF detection [<xref rid="R23" ref-type="bibr">23</xref>&#x02013;<xref rid="R25" ref-type="bibr">25</xref>]. We
consider that Kardia may be combined with the relational agent described here to use
the two synergistically. Kardia may facilitate correlation of symptoms reported to
the relational agent, and relational agent content may reciprocally encourage
individuals to take Kardia recordings. For example, patients may report symptoms to
the relational agent, which in turn could prompt relational agent content that
encourages Kardia use, and both applications may corroborate and support the
documentation provided by the other. As the use of the relational agent and Kardia
are time-stamped, the results may be incorporated as data to guide and direct
clinical management.</p><p id="P11">We developed a relational agent for AF that integrated with Kardia. We
sought to pilot this mHealth intervention and then use the results to guide the
development of the clinical trial, the Atrial Fibrillation Health Literacy
Information Technology Trial (AF-LITT), registered at <ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov">ClinicalTrials.gov</ext-link> (NCT03093558). We report here on the initial
pilot (n=31) of this mHealth intervention for preliminary results to guide
and enhance the randomized controlled trial (RCT).</p></sec><sec sec-type="methods" id="S7"><title>Methods</title><sec id="S8"><title>Relational Agent Development and Content</title><p id="P12">The intervention includes a computer-animated relational agent that
simulates a face-to-face conversation with a health counselor or coach using
synthetic speech that accompanies animated conversational behavior (<xref rid="F1" ref-type="fig">Figure 1</xref>) [<xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R27" ref-type="bibr">27</xref>]. Our prior
work has demonstrated that the relational agent as a vehicle for human-computer
interaction is accessible to individuals with limited computer literacy and to
older adults [<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R27" ref-type="bibr">27</xref>]. Our work has further shown that the relational agent
fosters a therapeutic alliance with patients of diverse socioeconomic
backgrounds and health literacy [<xref rid="R28" ref-type="bibr">28</xref>&#x02013;<xref rid="R30" ref-type="bibr">30</xref>].</p><p id="P13">Users make selections via the smartphone&#x02019;s touch screen, and
this selection directs further interaction and content provided by the
relational agent. Communication with users includes nonverbal conversational
behaviors, such as facial expressions for empathy or hand gestures for emphasis,
which reinforce communication and facilitate empathetic expression. The content
may be tailored for individual use, such that the relational agent addresses
users by name and appropriate time context (eg, Good morning). In addition, the
relational agent may be programmed to refer to prior content areas to obtain
repeated assessments and follow the resolution of reported problems. We provided
the agent with a name to facilitate user interaction, which is consistent with
our other relational agent interventions; in this case, we designated the agent
as &#x0201c;Tanya&#x0201d;.</p><p id="P14">The relational agent content was developed by review of patient-centered
domains, review of the literature, and qualitative interviews with patients with
AF. In brief, we had a focus group consisting of patients with AF and receiving
chronic anticoagulation. We asked patient participants open-ended questions
about their experience of AF and the challenges and gaps that they experienced
in their care. Our work is consistent with others in that the patients have a
poor understanding of the condition, experience myriad symptoms, and find
adherence challenging [<xref rid="R31" ref-type="bibr">31</xref>]. We consequently used these domains to develop the pilot of
the relational agent, listed in <xref rid="T1" ref-type="table">Table
1</xref>.</p><p id="P15">Education spanned the causes of AF and its associated risk factors,
treatments, and adverse events. Symptoms consisted of assessment of frequency
and severity of shortness of breath, chest pain or discomfort, fatigue, and
palpitations or the sensation of a racing or irregular heartbeat. Adherence
content focused on common challenges to medication adherence, such as
forgetfulness, affordability, access to medications, transportation, and the
patient-physician relationship, along with general strategies to address these
obstacles. Activation content entailed articulating goals of care and preparing
for the medical encounter. For the concomitant use of Kardia, users were
prompted to use Kardia daily and when they experienced symptoms.</p></sec><sec id="S9"><title>Relational Agent and Kardia Use Ascertainment</title><p id="P16">The relational agent application and the Kardia monitor transmitted
their data to a central server for monitoring, data collection, and analysis.
Relational agent data included the date and time of use, duration, and specific
domains of content accessed. Kardia data included the date of recording and
recording results with a classification of heart rhythm (AF, sinus, or other)
and heart rates in AF.</p></sec><sec id="S10"><title>Cohort Participants</title><p id="P17">Participants were recruited from a convenience cohort of patients with
prevalent AF, who were receiving care at ambulatory facilities of the University
of Pittsburgh Medical Center in Pittsburgh, PA. Inclusion criteria included
adult (age &#x02265;18), a diagnosis of nonvalvular AF as ascertained by review
of the electronic health record, CHA<sub>2</sub> DS<sub>2</sub>-VASc score
&#x02265;2 [<xref rid="R32" ref-type="bibr">32</xref>], and
receiving oral anticoagulation. Participants were excluded for having an
identified extracardiac cause of AF (such as sepsis or thyroid disease), as the
management of AF in such context may differ based upon the underlying etiology
[<xref rid="R2" ref-type="bibr">2</xref>]; inability to
provide accurate three-word recall; inability to provide informed consent; or
being non-English speaking. Individuals were provided with an iPhone 6 (Apple,
Cupertino, CA) for the duration of the study and instructions on the use of the
relational agent and Kardia system. The study was approved by the University of
Pittsburgh School of Medicine&#x02019;s Institutional Review Board.</p></sec><sec id="S11"><title>Participant Assessments</title><p id="P18">Age, race, smoking status, highest level of education (less than high
school, high school graduate, or vocational or trade school; some college with
no degree or associate degree; bachelor degree; or graduate or postcollege
professional school), and annual income (up to US $19,000; US
$20&#x02013;34,999; US $35&#x02013;49,999; US $50&#x02013;74,999; and
&#x02265;US $100,000) were obtained by participant self-report. Date of
diagnosis with AF was obtained by self-report and the medical record. Body mass
index (BMI) was calculated from weight (kg) divided by height (meters squared).
Smoking status (current or prior smoking) and pack-years were obtained by
self-report. Clinical covariates were derived from medical record problem lists
and included hypertension, diabetes, cardiovascular disease, heart failure, and
prior stroke or transient ischemic attack. Medications (anticoagulants,
antiarrhythmics, and rate control agents) and treatment for AF (history of
pharmacological or electrical cardioversion, pulmonary vein isolation) were
obtained by self-report with corroboration from the medical record. Health
literacy was measured by the Short-Test of Functional Health Literacy in Adults
(S-TOFHLA) [<xref rid="R33" ref-type="bibr">33</xref>], which
was selected for its broad use as a measure for health literacy assessment,
scored from 1 to 36, with a score of &#x02264;23 indicating limited health
literacy.</p><p id="P19">The Atrial Fibrillation Effect on Quality of life (AFEQT) [<xref rid="R34" ref-type="bibr">34</xref>], the Morisky 8-item Medication
Adherence Scale (MMAS-8) [<xref rid="R35" ref-type="bibr">35</xref>], and the Patient Activation Measure (PAM) [<xref rid="R36" ref-type="bibr">36</xref>] were administered to
participants at baseline and at study completion, that is, day 30. HRQoL was
ascertained with the AFEQT questionnaire, a validated instrument specific to
AF-related HRQoL. The AFEQT consists of a 20-item instrument that measures the
effects of AF on HRQoL in the domains of symptoms, daily activities, treatment
concerns, and treatment satisfaction, in addition to providing a global measure.
Scores range from 0 to 100, with higher scores indicating superior HRQoL.
Medication adherence was determined by self-report with the MMAS-8, which has
been validated in diverse clinical conditions and is additionally used in
studies of participants with limited health literacy [<xref rid="R37" ref-type="bibr">37</xref>,<xref rid="R38" ref-type="bibr">38</xref>]. The MMAS-8 ranges from 0 to 8, with higher scores
indicating greater medication adherence. The 13-item PAM was used to ascertain
patient activation, which has been conceptualized as the confidence, skills, and
knowledge for patient self-management. PAM scores are tabulated from 0 to 100
and then converted from level 0 to level 5 as described elsewhere [<xref rid="R39" ref-type="bibr">39</xref>]. We elected not to include an
assessment of AF patient knowledge, as the evidence that patient knowledge
improves medication adherence in AF is scant [<xref rid="R40" ref-type="bibr">40</xref>].</p></sec><sec id="S12"><title>Coaching, Acceptability, and Remuneration</title><p id="P20">Participants were contacted by telephone at their primary phone number
on days 7, 14, and 21 to discuss problems with using the relational agent or
Kardia. Individuals without relational agent use for &#x02265;3 days were
additionally contacted for support and troubleshooting. Qualitative interviews
were conducted with participants at 30 days. Participants completed a 22-item
instrument that evaluated their experience with the relational agent using
7-point Likert scale items. Pilot study participants received US $20 for the
initial and final visit, and they were provided with a payment of US $1/day each
for the use of the relational agent and Kardia, as an incentive for use and
continued adherence. Therefore, the participants were able to receive a maximum
of US $100 for two study visits and 30-day use of both instruments.</p></sec><sec id="S13"><title>Statistical Analysis</title><p id="P21">We summarized the distributions of categorical and continuous variables.
We used paired, 2-tailed <italic>t</italic> tests to examine the differences at
baseline and 30 days in HRQoL with the AFEQT, self-reported adherence with the
MMAS-8, and patient activation with the PAM. A <italic>P</italic> value of
&#x0003c;.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="S14"><title>Results</title><p id="P22">The pilot cohort enrolled 31 participants with a mean age of 68 (SD 11)
years, 39% of the participants were women, and predominantly belonging to
the white race (94%, 29/31). Further characteristics of the cohort, which
are summarized in <xref rid="T2" ref-type="table">Table 2</xref>, included both
limited education (not having completed college, 68%, 21/31) and annual
income (&#x0003c;US $35,000, 39%, 12/31; with the majority reporting
&#x0003c;US $19,000). Obesity was common, with a mean BMI of 30.8 (SD 8.1), and
multiple participants had diabetes, cardiovascular disease, a history of heart
failure, or prior stroke or transient ischemic attack.</p><p id="P23">Study participants used the relational agent for a range extending from 3 to
30 days, with a median of 20 days&#x02019; usage that averaged 17.8 (SD 10.0) days
of use. The number of log-ins to the relational agent ranged from 4 to 43, with a
median of 20 and average of 19.6 (SD 10.7) uses. The median number of Kardia uses
was 29, extending from 5 to 30, with a mean of 26.5 (SD 5.9) uses. Participants were
in AF, a median of 13 days during the 30-day study period.</p><p id="P24">The baseline and 30-day assessments of AFEQT, self-reported adherence, and
PAM scores are summarized in <xref rid="T3" ref-type="table">Table 3</xref>. The
global AFEQT score was significantly improved from baseline to day 30, as was the
daily activity component of the AFEQT. The domains of symptoms and treatment
concerns had improvement from baseline to day 30 that was not statistically
significant. The AFEQT domain of treatment satisfaction remained unchanged from
baseline to day 30. Self-reported adherence with the MMAS-8 was marginally but
significantly improved. The improvement in patient activation as measured by the PAM
did not reach statistical significance.</p><p id="P25">Our postuse assessments of the relational agent showed moderately strong
acceptability of the agent. Thirteen of 31 participants reported either 6 or 7 on a
7-point Likert scale (1=Not at all; 7=Very satisfied) concerning
their satisfaction with Tanya. Twenty-three participants selected 1 on the 7-point
Likert scale, indicating that talking with Tanya was easy (1=Easy;
7=Difficult). When asked about continuing to work with Tanya, 17 indicated a
strong willingness to continue, 9 would consider continuing with additional modules,
whereas 5 indicated no interest. When scoring how much participants liked Tanya, 21
indicated a 5 or higher on the 7-point Likert scale (1=Not at all;
7=Very much). Participants further endorsed comfort with the agent and a
belief that the agent is genuinely concerned about their welfare. These results and
the remaining assessments of participants&#x02019; experience with the relational
agent are summarized in <xref rid="T4" ref-type="table">Table 4</xref>.</p></sec><sec sec-type="discussion" id="S15"><title>Discussion</title><sec id="S16"><title>Principal Findings</title><p id="P26">We piloted a 30-day intervention that combined a smartphone-based
relational agent and the AliveCor Kardia heart rhythm monitor. Our chief
findings were that the participants in this small-sized pilot reported improved
HRQoL specific to AF and self-reported medication adherence. We tracked use of
the relational agent and Kardia and identified that participants used them
reliably over the 30-day intervention period. Finally, we demonstrated that the
relational agent developed for this intervention had moderate to high
acceptability by study participants.</p><p id="P27">There is a growing interest in mHealth to enhance patient engagement and
improve patient outcomes. Our work focuses on implementing a relational agent,
termed here the relational agent, which has distinct advantages as a mHealth
intervention. The agent uses conversational behaviors&#x02014;empathic tone,
hand gestures, and facial expressions&#x02014;to convey information. The
responses to our postsurvey acceptability assessment suggest that users find the
agent accessible, informative, and trustworthy. These results are similar to our
prior work with relational agents, where we have used the relational agent as a
nonjudgmental, empathetic coach to offer patient-centered guidance
[<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R41" ref-type="bibr">41</xref>,<xref rid="R42" ref-type="bibr">42</xref>]. Relational agents provide an effective medium for health
communication and counseling, especially for patients with limited health
literacy. Health literacy is associated with poor self-management in multiple
diverse conditions [<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R43" ref-type="bibr">43</xref>&#x02013;<xref rid="R45" ref-type="bibr">45</xref>]. In our prior work, we have used the relational agent to
improve health outcomes in individuals with limited health literacy
[<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R27" ref-type="bibr">27</xref>]
and have developed the content of our relational agent for AF to be accessible
for such individuals. Health literacy has relevance to mHealth development,
accessibility, and successful implementation; mHealth focused toward health
literacy has the potential to reduce disparities in vulnerable populations,
where limited health literacy is more prevalent [<xref rid="R27" ref-type="bibr">27</xref>].</p><p id="P28">In addition, the relational agent has the potential to assist users in
real time. Content may be programmed to address immediate problems, suggest
solutions, and then track their resolution. The relational agent content used in
this pilot focused on major symptoms and then inquired about their status. Such
content and the monitoring of responses may be implemented in conjunction with
the Kardia. Thus, it is feasible to track symptoms while assessing their
correlation with simultaneous heart rhythm or rate monitoring. In our next
iteration, we expect to use symptoms and Kardia rate and rhythm monitoring to
guide interventions in real time. We expect in our RCT to follow participants
prospectively and longitudinally using a dashboard; so, we can respond to assist
clinicians with enhanced management strategies.</p><p id="P29">The relational agent can promote self-management that is central to
success with a chronic disease. The self-management model recognizes chronic
disease management as a long-term endeavor with an uncertain prognosis and
varied course [<xref rid="R46" ref-type="bibr">46</xref>]. AF is
well suited for the self-management model because of its complex treatments, the
potential for myriad complications, and necessity of patient adherence and
engagement. We have developed our relational agent content guided by the
self-management model because of the focus on sustained self-care and prevention
in a chronic disease such as AF. The relational agent can promote patient
education essential to self-management [<xref rid="R47" ref-type="bibr">47</xref>]. mHealth interventions that promote the self-management
model must have the capacity to address the long-term aspects of chronic disease
management. The relational agent is well suited, given its accessibility by a
smartphone and capacity for expanded content delivered by the agent.</p><p id="P30">The adverse impact of AF on HRQoL has been well established
[<xref rid="R48" ref-type="bibr">48</xref>&#x02013;<xref rid="R50" ref-type="bibr">50</xref>]. The strengths of the AFEQT include its
validation and development as a measure specific to AF [<xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R51" ref-type="bibr">51</xref>]. A systematic review concluded that the AFEQT has stronger
construct validity than other HRQoL measures specific to AF [<xref rid="R52" ref-type="bibr">52</xref>]. HRQoL has received increased
emphasis as a patient-reported outcome, but it remains absent from many
cardiovascular trials, including those focused on AF [<xref rid="R53" ref-type="bibr">53</xref>]. Although we observed a significant
difference in baseline and 30-day AFEQT scores, the change did not meet the
19-unit, minimal important difference in the instrument that has previously been
identified [<xref rid="R51" ref-type="bibr">51</xref>]. However,
that threshold for a minimal important difference was ascertained over 3 months
in a much larger cohort (n=210). In addition, we observed significant
changes in the global AFEQT score and its domain of daily activities, and a
trend toward improvement in symptoms and treatment concerns that did not reach
our threshold for statistical significance. We did not observe improvement in
treatment satisfaction, possibly because our 30-day intervention was too limited
in duration for participants&#x02019; treatment to undergo modification. We
intend to conduct a more sustained intervention, which will provide confirmation
of the efficacy of the relational agent to improve HRQoL. Real-time monitoring
with targeted interventions may also improve treatment satisfaction.</p><p id="P31">Medication adherence is a prominent goal for chronic disease management
and crucial in AF. In addition to increased medical costs and hospitalization
risk, AF is associated with adverse events such as strokes and heart failure.
Strokes may be prevented with regular use of anticoagulation, either vitamin K
antagonist, such as warfarin, or one of the newer oral anticoagulants that do
not require routine monitoring. However, poor adherence to anticoagulation in AF
is common.</p><p id="P32">Discontinuation rates in clinical trials for the novel oral
anticoagulants (NOAC) were 15% to 34% [<xref rid="R54" ref-type="bibr">54</xref>&#x02013;<xref rid="R56" ref-type="bibr">56</xref>]. Claims data indicate that only 49% to 67%
of NOAC users have satisfactory fill rates 9 to 12 months following the initial
prescription [<xref rid="R57" ref-type="bibr">57</xref>,<xref rid="R58" ref-type="bibr">58</xref>]. For warfarin users, annual
discontinuation reaches 27% to 33% [<xref rid="R59" ref-type="bibr">59</xref>]. Clinical trials and registries further
affirm high discontinuation rates for both warfarin and NOAC users
[<xref rid="R57" ref-type="bibr">57</xref>,<xref rid="R60" ref-type="bibr">60</xref>]. As AF is a lifelong condition,
deescalation of anticoagulation is only justified if continued treatment is
contraindicated, and long-term adherence is essential for stroke prevention. We
expect to continue to refine and develop the relational agent used in this
application. Our goals include enhanced adherence content for active problem
solving of adherence challenges and obstacles; determining the reliability of
the relational agent to measure adherence, compared with a gold standard such as
medication event monitoring systems; and measuring the efficacy of the
relational agent to improve adherence using objective measures rather than
relying on self-reporting, which is subject to multiple biases [<xref rid="R61" ref-type="bibr">61</xref>].</p></sec><sec id="S17"><title>Limitations</title><p id="P33">We also consider that our pilot study reported here has important
limitations. First, the study sample was small (n=31), selected as a
convenience cohort, and without randomization. We recognize a biased selection
approach that may likely influence our results. For example, individuals
recruited for this pilot may be more enthusiastic about the use of new
technology, and they, consequently, demonstrate a greater likelihood of daily
use than a more generalizable cohort. Second, individuals received repeated
assessments using the same instruments over the 30-day study period. It is
possible that the repeat measurement may modify or influence
participant&#x02019;s self-report of HRQoL or medication adherence. Third,
participants were contacted during the study and offered support using the
technology. Participants&#x02019; use of the intervention may have been
influenced by such contact. However, for mHealth to be successful, it must be
accessible to users. Fourth, our limited pilot cohort is racially homogeneous,
as only 2 participants belonged to the nonwhite race. Enhanced recruitment of
ethnic and racial minorities&#x02014;those most likely to experience more severe
differences in AF outcomes [<xref rid="R62" ref-type="bibr">62</xref>]&#x02014;is critical to address disparities in AF. Fifth, we
recruited from a limited number of ambulatory sites without control for practice
patterns or clinical approaches. It is possible that there is residual
confounding due to how clinicians caring for such a small-sized cohort may
approach AF. Sixth, we had variable adherence to the intervention in this pilot.
We are using these results to refine and improve relational agent content.
Finally, the statistical assessments used to compare the baseline and 30-day
measures were not adjusted for age, sex, and duration of AF, health literacy or
other covariates. Such factors may have influenced adherence to the relational
agent and consistency of use. Given our small sample size, stratified analyses
would neither be statistically efficient nor meaningful. Furthermore,
identifying which components of the multifaceted intervention promoted use would
be challenging in this sample size. In subsequent, larger studies, we intend to
measure the effects of the relational agent on prespecified subgroups.</p></sec><sec id="S18"><title>Conclusions</title><p id="P34">In conclusion, we present results on the pilot use of a smartphone-based
relational agent in combination with heart rate and rhythm monitoring. In our
limited-sized pilot study conducted over 30 days, we identified strong adherence
to the intervention and showed significant improvements in HRQoL and
self-reported adherence. Participants found the relational agent acceptable.
These results will guide the development and implementation of a more
comprehensive relational agent for guiding long-term AF management to improve
patient self-management and the experience of a highly morbid condition.</p></sec></sec></body><back><ack id="S19"><p>This work was supported by Grant 2015084 from the Doris Duke Charitable Foundation.
The authors are solely responsible for the design and conduct of this study, all
study analyses, as well as the drafting and editing of the manuscript and its final
contents.</p></ack><fn-group><fn fn-type="COI-statement" id="FN2"><p><bold>Conflicts of Interest</bold></p><p>None declared.</p></fn></fn-group><glossary id="GL1"><title>Abbreviations</title><def-list><def-item><term id="G1">AF</term><def><p>atrial fibrillation</p></def></def-item><def-item><term id="G2">AF-LITT</term><def><p>Atrial Fibrillation Health Literacy Information Technology Trial</p></def></def-item><def-item><term id="G3">AFEQT</term><def><p>Atrial Fibrillation Effect on Quality of life</p></def></def-item><def-item><term id="G4">HRQoL</term><def><p>health-related quality of life</p></def></def-item><def-item><term id="G5">mHealth</term><def><p>mobile health</p></def></def-item><def-item><term id="G6">MMAS-8</term><def><p>Morisky 8-item Medication Adherence Scale</p></def></def-item><def-item><term id="G7">NOAC</term><def><p>novel oral anticoagulants</p></def></def-item><def-item><term id="G8">PAM</term><def><p>Patient Activation Measure</p></def></def-item><def-item><term id="G9">S-TOFHLA</term><def><p>Short-Test of Functional Health Literacy in Adults</p></def></def-item></def-list></glossary><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Writing Group Members</collab><name><surname>Mozaffarian</surname><given-names>D</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Go</surname><given-names>AS</given-names></name><name><surname>Arnett</surname><given-names>DK</given-names></name><name><surname>Blaha</surname><given-names>MJ</given-names></name><collab>American Heart Association Statistics Committee, Stroke Statistics
Subcommittee</collab></person-group><article-title>Heart disease and stroke statistics-2016 update: a report from
the American Heart Association</article-title><source>Circulation</source><year>2016</year><month>1</month><day>26</day><volume>133</volume><issue>4</issue><fpage>e38</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1161/CIR.0000000000000350</pub-id><pub-id pub-id-type="pmid">26673558</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>January</surname><given-names>CT</given-names></name><name><surname>Wann</surname><given-names>LS</given-names></name><name><surname>Alpert</surname><given-names>JS</given-names></name><name><surname>Calkins</surname><given-names>H</given-names></name><name><surname>Cigarroa</surname><given-names>JE</given-names></name><name><surname>Cleveland</surname><given-names>JC</given-names><suffix>Jr</suffix></name><collab>ACC/AHA Task Force Members</collab></person-group><article-title>2014 AHA/ACC/HRS guideline for the management of patients with
atrial fibrillation: a report of the American College of Cardiology/American
Heart Association Task Force on practice guidelines and the Heart Rhythm
Society</article-title><source>Circulation</source><year>2014</year><month>12</month><day>02</day><volume>130</volume><issue>23</issue><fpage>e199</fpage><lpage>e267</lpage><pub-id pub-id-type="doi">10.1161/CIR.0000000000000041</pub-id><pub-id pub-id-type="pmid">24682347</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magnani</surname><given-names>JW</given-names></name><name><surname>Rienstra</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Sinner</surname><given-names>MF</given-names></name><name><surname>Lubitz</surname><given-names>SA</given-names></name><name><surname>McManus</surname><given-names>DD</given-names></name><etal/></person-group><article-title>Atrial fibrillation: current knowledge and future directions in
epidemiology and genomics</article-title><source>Circulation</source><year>2011</year><month>11</month><day>01</day><volume>124</volume><issue>18</issue><fpage>1982</fpage><lpage>1993</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.039677</pub-id><pub-id pub-id-type="pmid">22042927</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suman-Horduna</surname><given-names>I</given-names></name><name><surname>Roy</surname><given-names>D</given-names></name><name><surname>Frasure-Smith</surname><given-names>N</given-names></name><name><surname>Talajic</surname><given-names>M</given-names></name><name><surname>Lesp&#x000e9;rance</surname><given-names>F</given-names></name><name><surname>Blondeau</surname><given-names>L</given-names></name><collab>AF-CHF Trial Investigators</collab></person-group><article-title>Quality of life and functional capacity in patients with atrial
fibrillation and congestive heart failure</article-title><source>J Am Coll Cardiol</source><year>2013</year><month>1</month><day>29</day><volume>61</volume><issue>4</issue><fpage>455</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2012.10.031</pub-id><pub-id pub-id-type="pmid">23265334</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groenveld</surname><given-names>HF</given-names></name><name><surname>Crijns</surname><given-names>HJ</given-names></name><name><surname>Van den Berg</surname><given-names>MP</given-names></name><name><surname>Van Sonderen</surname><given-names>E</given-names></name><name><surname>Alings</surname><given-names>AM</given-names></name><name><surname>Tijssen</surname><given-names>JG</given-names></name><collab>RACE II Investigators</collab></person-group><article-title>The effect of rate control on quality of life in patients with
permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy
in Permanent Atrial Fibrillation II) study</article-title><source>J Am Coll Cardiol</source><year>2011</year><month>10</month><day>18</day><volume>58</volume><issue>17</issue><fpage>1795</fpage><lpage>1803</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2011.06.055</pub-id><pub-id pub-id-type="pmid">21996393</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherian</surname><given-names>TS</given-names></name><name><surname>Shrader</surname><given-names>P</given-names></name><name><surname>Fonarow</surname><given-names>GC</given-names></name><name><surname>Allen</surname><given-names>LA</given-names></name><name><surname>Piccini</surname><given-names>JP</given-names></name><name><surname>Peterson</surname><given-names>ED</given-names></name><etal/></person-group><article-title>Effect of atrial fibrillation on mortality, stroke risk, and
quality-of-life scores in patients with heart failure (from the Outcomes
Registry for Better Informed Treatment of Atrial Fibrillation
[ORBIT-AF])</article-title><source>Am J Cardiol</source><year>2017</year><month>6</month><day>01</day><volume>119</volume><issue>11</issue><fpage>1763</fpage><lpage>1769</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2017.02.050</pub-id><pub-id pub-id-type="pmid">28416199</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aronis</surname><given-names>KN</given-names></name><name><surname>Edgar</surname><given-names>B</given-names></name><name><surname>Lin</surname><given-names>W</given-names></name><name><surname>Martins</surname><given-names>MA</given-names></name><name><surname>Paasche-Orlow</surname><given-names>MK</given-names></name><name><surname>Magnani</surname><given-names>JW</given-names></name></person-group><article-title>Health literacy and atrial fibrillation: relevance and future
directions for patient-centred care</article-title><source>Eur Cardiol</source><year>2017</year><volume>12</volume><issue>1</issue><fpage>52</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.15420/ecr.2017:2:2</pub-id><pub-id pub-id-type="pmid">28936235</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCorkle</surname><given-names>R</given-names></name><name><surname>Ercolano</surname><given-names>E</given-names></name><name><surname>Lazenby</surname><given-names>M</given-names></name><name><surname>Schulman-Green</surname><given-names>D</given-names></name><name><surname>Schilling</surname><given-names>LS</given-names></name><name><surname>Lorig</surname><given-names>K</given-names></name><etal/></person-group><article-title>Self-management: enabling and empowering patients living with
cancer as a chronic illness</article-title><source>CA Cancer J Clin</source><year>2011</year><volume>61</volume><issue>1</issue><fpage>50</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.3322/caac.20093</pub-id><pub-id pub-id-type="pmid">21205833</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickmore</surname><given-names>TW</given-names></name><name><surname>Utami</surname><given-names>D</given-names></name><name><surname>Matsuyama</surname><given-names>R</given-names></name><name><surname>Paasche-Orlow</surname><given-names>MK</given-names></name></person-group><article-title>Improving access to online health information with conversational
agents: a randomized controlled experiment</article-title><source>J Med Internet Res</source><year>2016</year><volume>18</volume><issue>1</issue><fpage>e1</fpage><pub-id pub-id-type="doi">10.2196/jmir.5239</pub-id><pub-id pub-id-type="pmid">26728964</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Bickmore</surname><given-names>T</given-names></name><name><surname>Bowen</surname><given-names>DJ</given-names></name><name><surname>Norkunas</surname><given-names>T</given-names></name><name><surname>Campion</surname><given-names>M</given-names></name><name><surname>Cabral</surname><given-names>H</given-names></name><etal/></person-group><article-title>Acceptability and feasibility of a virtual counselor (VICKY) to
collect family health histories</article-title><source>Genet Med</source><year>2015</year><month>10</month><volume>17</volume><issue>10</issue><fpage>822</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1038/gim.2014.198</pub-id><pub-id pub-id-type="pmid">25590980</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sequeira</surname><given-names>SS</given-names></name><name><surname>Eggermont</surname><given-names>LH</given-names></name><name><surname>Silliman</surname><given-names>RA</given-names></name><name><surname>Bickmore</surname><given-names>TW</given-names></name><name><surname>Henault</surname><given-names>LE</given-names></name><name><surname>Winter</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Limited health literacy and decline in executive function in
older adults</article-title><source>J Health Commun</source><year>2013</year><volume>18</volume><issue>Suppl 1</issue><fpage>143</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1080/10810730.2013.825673</pub-id><pub-id pub-id-type="pmid">24093352</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickmore</surname><given-names>TW</given-names></name><name><surname>Silliman</surname><given-names>RA</given-names></name><name><surname>Nelson</surname><given-names>K</given-names></name><name><surname>Cheng</surname><given-names>DM</given-names></name><name><surname>Winter</surname><given-names>M</given-names></name><name><surname>Henault</surname><given-names>L</given-names></name><etal/></person-group><article-title>A randomized controlled trial of an automated exercise coach for
older adults</article-title><source>J Am Geriatr Soc</source><year>2013</year><month>10</month><volume>61</volume><issue>10</issue><fpage>1676</fpage><lpage>1683</lpage><pub-id pub-id-type="doi">10.1111/jgs.12449</pub-id><pub-id pub-id-type="pmid">24001030</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickmore</surname><given-names>TW</given-names></name><name><surname>Schulman</surname><given-names>D</given-names></name><name><surname>Sidner</surname><given-names>C</given-names></name></person-group><article-title>Automated interventions for multiple health behaviors using
conversational agents</article-title><source>Patient Educ Couns</source><year>2013</year><month>8</month><volume>92</volume><issue>2</issue><fpage>142</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/j.pec.2013.05.011</pub-id><pub-id pub-id-type="pmid">23763983</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname><given-names>T</given-names></name><name><surname>Latham</surname><given-names>NK</given-names></name><name><surname>DeAngelis</surname><given-names>TR</given-names></name><name><surname>Thomas</surname><given-names>CA</given-names></name><name><surname>Saint-Hilaire</surname><given-names>M</given-names></name><name><surname>Bickmore</surname><given-names>TW</given-names></name></person-group><article-title>Feasibility of a virtual exercise coach to promote walking in
community-dwelling persons with Parkinson disease</article-title><source>Am J Phys Med Rehabil</source><year>2013</year><month>6</month><volume>92</volume><issue>6</issue><fpage>472</fpage><lpage>81</lpage><comment>quiz 482</comment><pub-id pub-id-type="doi">10.1097/PHM.0b013e31828cd466</pub-id><pub-id pub-id-type="pmid">23552335</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickmore</surname><given-names>TW</given-names></name><name><surname>Silliman</surname><given-names>RA</given-names></name><name><surname>Nelson</surname><given-names>K</given-names></name><name><surname>Cheng</surname><given-names>DM</given-names></name><name><surname>Winter</surname><given-names>M</given-names></name><name><surname>Henault</surname><given-names>L</given-names></name><etal/></person-group><article-title>A randomized controlled trial of an automated exercise coach for
older adults</article-title><source>J Am Geriatr Soc</source><year>2013</year><month>10</month><volume>61</volume><issue>10</issue><fpage>1676</fpage><lpage>1683</lpage><pub-id pub-id-type="doi">10.1111/jgs.12449</pub-id><pub-id pub-id-type="pmid">24001030</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puskar</surname><given-names>K</given-names></name><name><surname>Schlenk</surname><given-names>EA</given-names></name><name><surname>Callan</surname><given-names>J</given-names></name><name><surname>Bickmore</surname><given-names>T</given-names></name><name><surname>Sereika</surname><given-names>S</given-names></name></person-group><article-title>Relational agents as an adjunct in schizophrenia
treatment</article-title><source>J Psychosoc Nurs Ment Health Serv</source><year>2011</year><month>8</month><volume>49</volume><issue>8</issue><fpage>22</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.3928/02793695-20110705-01</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickmore</surname><given-names>T</given-names></name><name><surname>Silliman</surname><given-names>R</given-names></name><name><surname>Nelson</surname><given-names>K</given-names></name><name><surname>Cheng</surname><given-names>D</given-names></name><name><surname>Winter</surname><given-names>M</given-names></name><name><surname>Henault</surname><given-names>L</given-names></name><etal/></person-group><article-title>A randomized controlled trial of an automated exercise coach for
older adults</article-title><source>J Am Geriatr Soc</source><year>2013</year><month>10</month><volume>61</volume><issue>10</issue><fpage>1676</fpage><lpage>1683</lpage><pub-id pub-id-type="doi">10.1111/jgs.12449</pub-id><pub-id pub-id-type="pmid">24001030</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickmore</surname><given-names>TW</given-names></name><name><surname>Puskar</surname><given-names>K</given-names></name><name><surname>Schlenk</surname><given-names>EA</given-names></name><name><surname>Pfeifer</surname><given-names>LM</given-names></name><name><surname>Sereika</surname><given-names>SM</given-names></name></person-group><article-title>Maintaining reality: relational agents for antipsychotic
medication adherence</article-title><source>Interact Comput</source><year>2010</year><month>7</month><day>01</day><volume>22</volume><issue>4</issue><fpage>276</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1016/j.intcom.2010.02.001</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickmore</surname><given-names>TW</given-names></name><name><surname>Pfeifer</surname><given-names>LM</given-names></name><name><surname>Paasche-Orlow</surname><given-names>MK</given-names></name></person-group><article-title>Using computer agents to explain medical documents to patients
with low health literacy</article-title><source>Patient Educ Couns</source><year>2009</year><month>6</month><volume>75</volume><issue>3</issue><fpage>315</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1016/j.pec.2009.02.007</pub-id><pub-id pub-id-type="pmid">19297116</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halcox</surname><given-names>JP</given-names></name><name><surname>Wareham</surname><given-names>K</given-names></name><name><surname>Cardew</surname><given-names>A</given-names></name><name><surname>Gilmore</surname><given-names>M</given-names></name><name><surname>Barry</surname><given-names>JP</given-names></name><name><surname>Phillips</surname><given-names>C</given-names></name><etal/></person-group><article-title>Assessment of remote heart rhythm sampling using the AliveCor
heart monitor to screen for atrial fibrillation: the REHEARSE-AF
study</article-title><source>Circulation</source><year>2017</year><month>11</month><day>07</day><volume>136</volume><issue>19</issue><fpage>1784</fpage><lpage>1794</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.117.030583</pub-id><pub-id pub-id-type="pmid">28851729</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinhubl</surname><given-names>SR</given-names></name><name><surname>Mehta</surname><given-names>RR</given-names></name><name><surname>Ebner</surname><given-names>GS</given-names></name><name><surname>Ballesteros</surname><given-names>MM</given-names></name><name><surname>Waalen</surname><given-names>J</given-names></name><name><surname>Steinberg</surname><given-names>G</given-names></name><etal/></person-group><article-title>Rationale and design of a home-based trial using wearable sensors
to detect asymptomatic atrial fibrillation in a targeted population: the
mHealth Screening To Prevent Strokes (mSToPS) trial</article-title><source>Am Heart J</source><year>2016</year><month>5</month><volume>175</volume><fpage>77</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.ahj.2016.02.011</pub-id><pub-id pub-id-type="pmid">27179726</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Pantelopoulos</surname><given-names>A</given-names></name><name><surname>Faranesh</surname><given-names>A</given-names></name><name><surname>Milescu</surname><given-names>A</given-names></name><name><surname>Hosking</surname><given-names>P</given-names></name><name><surname>Venkatraman</surname><given-names>S</given-names></name><collab>Heneghan C. iproc</collab></person-group><year>2017</year><source>Screening of Atrial Fibrillation Using Wrist Photoplethysmography from a
Fitbit Tracker</source><comment>URL: <ext-link ext-link-type="uri" xlink:href="http://www.iproc.org/2017/1/e17/">http://www.iproc.org/2017/1/e17/</ext-link> [accessed
2017-11-27]</comment></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hickey</surname><given-names>KT</given-names></name><name><surname>Hauser</surname><given-names>NR</given-names></name><name><surname>Valente</surname><given-names>LE</given-names></name><name><surname>Riga</surname><given-names>TC</given-names></name><name><surname>Frulla</surname><given-names>AP</given-names></name><name><surname>Masterson</surname><given-names>CR</given-names></name><etal/></person-group><article-title>A single-center randomized, controlled trial investigating the
efficacy of a mHealth ECG technology intervention to improve the detection
of atrial fibrillation: the iHEART study protocol</article-title><source>BMC Cardiovasc Disord</source><year>2016</year><month>7</month><day>16</day><volume>16</volume><fpage>152</fpage><pub-id pub-id-type="doi">10.1186/s12872-016-0327-y</pub-id><pub-id pub-id-type="pmid">27422639</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desteghe</surname><given-names>L</given-names></name><name><surname>Raymaekers</surname><given-names>Z</given-names></name><name><surname>Lutin</surname><given-names>M</given-names></name><name><surname>Vijgen</surname><given-names>J</given-names></name><name><surname>Dilling-Boer</surname><given-names>D</given-names></name><name><surname>Koopman</surname><given-names>P</given-names></name><etal/></person-group><article-title>Performance of handheld electrocardiogram devices to detect
atrial fibrillation in a cardiology and geriatric ward
setting</article-title><source>Europace</source><year>2017</year><month>1</month><volume>19</volume><issue>1</issue><fpage>29</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1093/europace/euw025</pub-id><pub-id pub-id-type="pmid">26893496</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarakji</surname><given-names>KG</given-names></name><name><surname>Wazni</surname><given-names>OM</given-names></name><name><surname>Callahan</surname><given-names>T</given-names></name><name><surname>Kanj</surname><given-names>M</given-names></name><name><surname>Hakim</surname><given-names>AH</given-names></name><name><surname>Wolski</surname><given-names>K</given-names></name><etal/></person-group><article-title>Using a novel wireless system for monitoring patients after the
atrial fibrillation ablation procedure: the iTransmit study</article-title><source>Heart Rhythm</source><year>2015</year><month>3</month><volume>12</volume><issue>3</issue><fpage>554</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1016/j.hrthm.2014.11.015</pub-id><pub-id pub-id-type="pmid">25460854</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickmore</surname><given-names>TW</given-names></name><name><surname>Pfeifer</surname><given-names>LM</given-names></name><name><surname>Byron</surname><given-names>D</given-names></name><name><surname>Forsythe</surname><given-names>S</given-names></name><name><surname>Henault</surname><given-names>LE</given-names></name><name><surname>Jack</surname><given-names>BW</given-names></name><etal/></person-group><article-title>Usability of conversational agents by patients with inadequate
health literacy: evidence from two clinical trials</article-title><source>J Health Commun</source><year>2010</year><volume>15</volume><issue>Suppl 2</issue><fpage>197</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1080/10810730.2010.499991</pub-id><pub-id pub-id-type="pmid">20845204</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickmore</surname><given-names>TW</given-names></name><name><surname>Paasche-Orlow</surname><given-names>MK</given-names></name></person-group><article-title>The role of information technology in health literacy
research</article-title><source>J Health Commun</source><year>2012</year><volume>17</volume><issue>Suppl 3</issue><fpage>23</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1080/10810730.2012.712626</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickmore</surname><given-names>T</given-names></name><name><surname>Gruber</surname><given-names>A</given-names></name><name><surname>Picard</surname><given-names>R</given-names></name></person-group><article-title>Establishing the computer-patient working alliance in automated
health behavior change interventions</article-title><source>Patient Educ Couns</source><year>2005</year><month>10</month><volume>59</volume><issue>1</issue><fpage>21</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.pec.2004.09.008</pub-id><pub-id pub-id-type="pmid">16198215</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickmore</surname><given-names>T</given-names></name><name><surname>Vardoulakis</surname><given-names>L</given-names></name><name><surname>Schulman</surname><given-names>D</given-names></name></person-group><article-title>Tinker: a relational agent museum guide</article-title><source>Auton Agent Multi-Agent Syst</source><year>2013</year><month>1</month><day>4</day><volume>27</volume><issue>2</issue><fpage>254</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1007/s10458-012-9216-7</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickmore</surname><given-names>T</given-names></name><name><surname>Schulman</surname><given-names>D</given-names></name><name><surname>Yin</surname><given-names>L</given-names></name></person-group><article-title>Maintaining engagement in long-term interventions with relational
agents</article-title><source>Appl Artif Intell</source><year>2010</year><month>7</month><day>01</day><volume>24</volume><issue>6</issue><fpage>648</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1080/08839514.2010.492259</pub-id><pub-id pub-id-type="pmid">21318052</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarkesmith</surname><given-names>DE</given-names></name><name><surname>Lip</surname><given-names>GY</given-names></name><name><surname>Lane</surname><given-names>DA</given-names></name></person-group><article-title>Patients&#x02019; experiences of atrial fibrillation and
non-vitamin K antagonist oral anticoagulants (NOACs), and their educational
needs: a qualitative study</article-title><source>Thromb Res</source><year>2017</year><month>5</month><volume>153</volume><fpage>19</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.thromres.2017.03.002</pub-id><pub-id pub-id-type="pmid">28314139</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lip</surname><given-names>GY</given-names></name><name><surname>Nieuwlaat</surname><given-names>R</given-names></name><name><surname>Pisters</surname><given-names>R</given-names></name><name><surname>Lane</surname><given-names>DA</given-names></name><name><surname>Crijns</surname><given-names>HJ</given-names></name></person-group><article-title>Refining clinical risk stratification for predicting stroke and
thromboembolism in atrial fibrillation using a novel risk factor-based
approach: the euro heart survey on atrial fibrillation</article-title><source>Chest</source><year>2010</year><month>2</month><volume>137</volume><issue>2</issue><fpage>263</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1378/chest.09-1584</pub-id><pub-id pub-id-type="pmid">19762550</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>DW</given-names></name><name><surname>Williams</surname><given-names>MV</given-names></name><name><surname>Parker</surname><given-names>RM</given-names></name><name><surname>Gazmararian</surname><given-names>JA</given-names></name><name><surname>Nurss</surname><given-names>J</given-names></name></person-group><article-title>Development of a brief test to measure functional health
literacy</article-title><source>Patient Educ Couns</source><year>1999</year><month>9</month><volume>38</volume><issue>1</issue><fpage>33</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">14528569</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spertus</surname><given-names>J</given-names></name><name><surname>Dorian</surname><given-names>P</given-names></name><name><surname>Bubien</surname><given-names>R</given-names></name><name><surname>Lewis</surname><given-names>S</given-names></name><name><surname>Godejohn</surname><given-names>D</given-names></name><name><surname>Reynolds</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Development and validation of the Atrial Fibrillation Effect on
QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial
fibrillation</article-title><source>Circ Arrhythm Electrophysiol</source><year>2011</year><month>2</month><volume>4</volume><issue>1</issue><fpage>15</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1161/CIRCEP.110.958033</pub-id><pub-id pub-id-type="pmid">21160035</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morisky</surname><given-names>DE</given-names></name><name><surname>Ang</surname><given-names>A</given-names></name><name><surname>Krousel-Wood</surname><given-names>M</given-names></name><name><surname>Ward</surname><given-names>HJ</given-names></name></person-group><article-title>Predictive validity of a medication adherence measure in an
outpatient setting</article-title><source>J Clin Hypertens (Greenwich)</source><year>2008</year><month>5</month><volume>10</volume><issue>5</issue><fpage>348</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">18453793</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hibbard</surname><given-names>JH</given-names></name><name><surname>Stockard</surname><given-names>J</given-names></name><name><surname>Mahoney</surname><given-names>ER</given-names></name><name><surname>Tusler</surname><given-names>M</given-names></name></person-group><article-title>Development of the Patient Activation Measure (PAM):
conceptualizing and measuring activation in patients and
consumers</article-title><source>Health Serv Res</source><year>2004</year><month>8</month><volume>39</volume><issue>4 Pt 1</issue><fpage>1005</fpage><lpage>1026</lpage><pub-id pub-id-type="doi">10.1111/j.1475-6773.2004.00269.x</pub-id><pub-id pub-id-type="pmid">15230939</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>GR</given-names></name><name><surname>Barner</surname><given-names>JC</given-names></name><name><surname>Weems</surname><given-names>JK</given-names></name><name><surname>Leckbee</surname><given-names>G</given-names></name><name><surname>Solis</surname><given-names>R</given-names></name><name><surname>Montemayor</surname><given-names>D</given-names></name><etal/></person-group><article-title>Assessing barriers to medication adherence in underserved
patients with diabetes in Texas</article-title><source>Diabetes Educ</source><year>2012</year><volume>38</volume><issue>2</issue><fpage>271</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1177/0145721711436134</pub-id><pub-id pub-id-type="pmid">22316643</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thurston</surname><given-names>MM</given-names></name><name><surname>Bourg</surname><given-names>CA</given-names></name><name><surname>Phillips</surname><given-names>BB</given-names></name><name><surname>Huston</surname><given-names>SA</given-names></name></person-group><article-title>Impact of health literacy level on aspects of medication
nonadherence reported by underserved patients with type 2
diabetes</article-title><source>Diabetes Technol Ther</source><year>2015</year><month>3</month><volume>17</volume><issue>3</issue><fpage>187</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1089/dia.2014.0220</pub-id><pub-id pub-id-type="pmid">25531555</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hibbard</surname><given-names>JH</given-names></name><name><surname>Mahoney</surname><given-names>ER</given-names></name><name><surname>Stockard</surname><given-names>J</given-names></name><name><surname>Tusler</surname><given-names>M</given-names></name></person-group><article-title>Development and testing of a short form of the patient activation
measure</article-title><source>Health Serv Res</source><year>2005</year><month>12</month><volume>40</volume><issue>6 Pt 1</issue><fpage>1918</fpage><lpage>1930</lpage><pub-id pub-id-type="doi">10.1111/j.1475-6773.2005.00438.x</pub-id><pub-id pub-id-type="pmid">16336556</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarkesmith</surname><given-names>DE</given-names></name><name><surname>Pattison</surname><given-names>HM</given-names></name><name><surname>Khaing</surname><given-names>PH</given-names></name><name><surname>Lane</surname><given-names>DA</given-names></name></person-group><article-title>Educational and behavioural interventions for anticoagulant
therapy in patients with atrial fibrillation</article-title><source>Cochrane Database Syst Rev</source><year>2017</year><month>12</month><volume>05</volume><volume>4</volume><fpage>CD008600</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD008600.pub3</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>AC</given-names></name><name><surname>Bickmore</surname><given-names>TW</given-names></name><name><surname>Campero</surname><given-names>MI</given-names></name><name><surname>Pruitt</surname><given-names>LA</given-names></name><name><surname>Yin</surname><given-names>JL</given-names></name></person-group><article-title>Employing virtual advisors in preventive care for underserved
communities: results from the COMPASS study</article-title><source>J Health Commun</source><year>2013</year><volume>18</volume><issue>12</issue><fpage>1449</fpage><lpage>1464</lpage><pub-id pub-id-type="doi">10.1080/10810730.2013.798374</pub-id><pub-id pub-id-type="pmid">23941610</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>A</given-names></name><name><surname>Bickmore</surname><given-names>T</given-names></name><name><surname>Cange</surname><given-names>A</given-names></name><name><surname>Kulshreshtha</surname><given-names>A</given-names></name><name><surname>Kvedar</surname><given-names>J</given-names></name></person-group><article-title>An internet-based virtual coach to promote physical activity
adherence in overweight adults: randomized controlled trial</article-title><source>J Med Internet Res</source><year>2012</year><volume>14</volume><issue>1</issue><fpage>e1</fpage><pub-id pub-id-type="doi">10.2196/jmir.1629</pub-id><pub-id pub-id-type="pmid">22281837</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>DW</given-names></name><name><surname>Wolf</surname><given-names>MS</given-names></name><name><surname>Feinglass</surname><given-names>J</given-names></name><name><surname>Thompson</surname><given-names>JA</given-names></name><name><surname>Gazmararian</surname><given-names>JA</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name></person-group><article-title>Health literacy and mortality among elderly
persons</article-title><source>Arch Intern Med</source><year>2007</year><month>7</month><day>23</day><volume>167</volume><issue>14</issue><fpage>1503</fpage><lpage>1509</lpage><pub-id pub-id-type="doi">10.1001/archinte.167.14.1503</pub-id><pub-id pub-id-type="pmid">17646604</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paasche-Orlow</surname><given-names>MK</given-names></name><name><surname>Wolf</surname><given-names>MS</given-names></name></person-group><article-title>The causal pathways linking health literacy to health
outcomes</article-title><source>Am J Health Behav</source><year>2007</year><volume>31</volume><issue>Suppl 1</issue><fpage>S19</fpage><lpage>S26</lpage><pub-id pub-id-type="doi">10.5555/ajhb.2007.31.supp.S19</pub-id><pub-id pub-id-type="pmid">17931132</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levinthal</surname><given-names>BR</given-names></name><name><surname>Morrow</surname><given-names>DG</given-names></name><name><surname>Tu</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Murray</surname><given-names>MD</given-names></name></person-group><article-title>Cognition and health literacy in patients with
hypertension</article-title><source>J Gen Intern Med</source><year>2008</year><month>8</month><volume>23</volume><issue>8</issue><fpage>1172</fpage><lpage>1176</lpage><pub-id pub-id-type="doi">10.1007/s11606-008-0612-2</pub-id><pub-id pub-id-type="pmid">18459011</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holman</surname><given-names>H</given-names></name><name><surname>Lorig</surname><given-names>K</given-names></name></person-group><article-title>Patient self-management: a key to effectiveness and efficiency in
care of chronic disease</article-title><source>Public Health Rep</source><year>2004</year><volume>119</volume><issue>3</issue><fpage>239</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1016/j.phr.2004.04.002</pub-id><pub-id pub-id-type="pmid">15158102</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holman</surname><given-names>HR</given-names></name><name><surname>Lorig</surname><given-names>KR</given-names></name></person-group><article-title>Patient education: essential to good health care for patients
with chronic arthritis</article-title><source>Arthritis Rheum</source><year>1997</year><month>8</month><volume>40</volume><issue>8</issue><fpage>1371</fpage><lpage>1373</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://10.1002/1529-0131.(199708)40:8&#x0003c;1371">10.1002/1529-0131.(199708)40:8&#x0003c;1371</ext-link></comment><pub-id pub-id-type="pmid">9259414</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mar</surname><given-names>CM</given-names></name><name><surname>Vivancos</surname><given-names>J</given-names></name><name><surname>Reig</surname><given-names>G</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>A</given-names></name><name><surname>Cardona</surname><given-names>P</given-names></name><name><surname>Ram&#x000ed;rez-Moreno</surname><given-names>JM</given-names></name><collab>ALADIN Study Investigators</collab></person-group><article-title>Satisfaction, quality of life and perception of patients
regarding burdens and benefits of vitamin K antagonists compared with direct
oral anticoagulants in patients with nonvalvular atrial
fibrillation</article-title><source>J Comp Eff Res</source><year>2017</year><month>3</month><day>29</day><volume>6</volume><issue>4</issue><fpage>303</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.2217/cer-2016-0078</pub-id><pub-id pub-id-type="pmid">28353372</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akintade</surname><given-names>BF</given-names></name><name><surname>Chapa</surname><given-names>D</given-names></name><name><surname>Friedmann</surname><given-names>E</given-names></name><name><surname>Thomas</surname><given-names>SA</given-names></name></person-group><article-title>The influence of depression and anxiety symptoms on
health-related quality of life in patients with atrial fibrillation and
atrial flutter</article-title><source>J Cardiovasc Nurs</source><year>2015</year><volume>30</volume><issue>1</issue><fpage>66</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1097/JCN.0000000000000107</pub-id><pub-id pub-id-type="pmid">24165697</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Gallagher</surname><given-names>R</given-names></name><name><surname>Neubeck</surname><given-names>L</given-names></name></person-group><article-title>Health-related quality of life in atrial fibrillation patients
over 65 years: a review</article-title><source>Eur J Prev Cardiol</source><year>2015</year><month>8</month><volume>22</volume><issue>8</issue><fpage>987</fpage><lpage>1002</lpage><pub-id pub-id-type="doi">10.1177/2047487314538855</pub-id><pub-id pub-id-type="pmid">24924742</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorian</surname><given-names>P</given-names></name><name><surname>Burk</surname><given-names>C</given-names></name><name><surname>Mullin</surname><given-names>CM</given-names></name><name><surname>Bubien</surname><given-names>R</given-names></name><name><surname>Godejohn</surname><given-names>D</given-names></name><name><surname>Reynolds</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Interpreting changes in quality of life in atrial fibrillation:
how much change is meaningful?</article-title><source>Am Heart J</source><year>2013</year><month>8</month><volume>166</volume><issue>2</issue><fpage>381</fpage><lpage>387.e8</lpage><pub-id pub-id-type="doi">10.1016/j.ahj.2013.04.015</pub-id><pub-id pub-id-type="pmid">23895823</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotecha</surname><given-names>D</given-names></name><name><surname>Ahmed</surname><given-names>A</given-names></name><name><surname>Calvert</surname><given-names>M</given-names></name><name><surname>Lencioni</surname><given-names>M</given-names></name><name><surname>Terwee</surname><given-names>CB</given-names></name><name><surname>Lane</surname><given-names>DA</given-names></name></person-group><article-title>Patient-reported outcomes for quality of life assessment in
atrial fibrillation: a systematic review of measurement
properties</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><issue>11</issue><fpage>e0165790</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0165790</pub-id><pub-id pub-id-type="pmid">27802324</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mark</surname><given-names>DB</given-names></name></person-group><article-title>Assessing quality-of-life outcomes in cardiovascular clinical
research</article-title><source>Nat Rev Cardiol</source><year>2016</year><month>5</month><volume>13</volume><issue>5</issue><fpage>286</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1038/nrcardio.2016.10</pub-id><pub-id pub-id-type="pmid">26888169</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connolly</surname><given-names>SJ</given-names></name><name><surname>Ezekowitz</surname><given-names>MD</given-names></name><name><surname>Yusuf</surname><given-names>S</given-names></name><name><surname>Eikelboom</surname><given-names>J</given-names></name><name><surname>Oldgren</surname><given-names>J</given-names></name><name><surname>Parekh</surname><given-names>A</given-names></name><etal/></person-group><article-title>Dabigatran versus warfarin in patients with atrial
fibrillation</article-title><source>N Engl J Med</source><year>2009</year><month>9</month><day>17</day><volume>361</volume><issue>12</issue><fpage>1139</fpage><lpage>1151</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0905561</pub-id><pub-id pub-id-type="pmid">19717844</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granger</surname><given-names>CB</given-names></name><name><surname>Alexander</surname><given-names>JH</given-names></name><name><surname>McMurray</surname><given-names>JJV</given-names></name><name><surname>Lopes</surname><given-names>RD</given-names></name><name><surname>Hylek</surname><given-names>EM</given-names></name><name><surname>Hanna</surname><given-names>M</given-names></name><etal/></person-group><article-title>Apixaban versus warfarin in patients with atrial
fibrillation</article-title><source>N Engl J Med</source><year>2011</year><month>9</month><day>15</day><volume>365</volume><issue>11</issue><fpage>981</fpage><lpage>992</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1107039</pub-id><pub-id pub-id-type="pmid">21870978</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>MR</given-names></name><name><surname>Mahaffey</surname><given-names>KW</given-names></name><name><surname>Garg</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>G</given-names></name><name><surname>Singer</surname><given-names>DE</given-names></name><name><surname>Hacke</surname><given-names>W</given-names></name><etal/></person-group><article-title>Rivaroxaban versus warfarin in nonvalvular atrial
fibrillation</article-title><source>N Engl J Med</source><year>2011</year><month>9</month><day>08</day><volume>365</volume><issue>10</issue><fpage>883</fpage><lpage>891</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1009638</pub-id><pub-id pub-id-type="pmid">21830957</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>JD</given-names></name><name><surname>Shewale</surname><given-names>AR</given-names></name><name><surname>Talbert</surname><given-names>JC</given-names></name></person-group><article-title>Adherence to Rivaroxaban, Dabigatran, and Apixaban for stroke
prevention in incident, treatment-na&#x000ef;ve nonvalvular atrial
fibrillation</article-title><source>J Manag Care Spec Pharm</source><year>2016</year><month>11</month><volume>22</volume><issue>11</issue><fpage>1319</fpage><lpage>1329</lpage><pub-id pub-id-type="doi">10.18553/jmcp.2016.22.11.1319</pub-id><pub-id pub-id-type="pmid">27783556</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beyer-Westendorf</surname><given-names>J</given-names></name><name><surname>Ehlken</surname><given-names>B</given-names></name><name><surname>Evers</surname><given-names>T</given-names></name></person-group><article-title>Real-world persistence and adherence to oral anticoagulation for
stroke risk reduction in patients with atrial fibrillation</article-title><source>Europace</source><year>2016</year><month>8</month><volume>18</volume><issue>8</issue><fpage>1150</fpage><lpage>1157</lpage><pub-id pub-id-type="doi">10.1093/europace/euv421</pub-id><pub-id pub-id-type="pmid">26830891</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>MC</given-names></name><name><surname>Go</surname><given-names>AS</given-names></name><name><surname>Chang</surname><given-names>Y</given-names></name><name><surname>Borowsky</surname><given-names>LH</given-names></name><name><surname>Pomernacki</surname><given-names>NK</given-names></name><name><surname>Udaltsova</surname><given-names>N</given-names></name><etal/></person-group><article-title>Warfarin discontinuation after starting warfarin for atrial
fibrillation</article-title><source>Circ Cardiovasc Qual Outcomes</source><year>2010</year><month>11</month><volume>3</volume><issue>6</issue><fpage>624</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.110.937680</pub-id><pub-id pub-id-type="pmid">20959565</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname><given-names>LA</given-names></name><name><surname>Ortiz</surname><given-names>M</given-names></name><name><surname>Freedman</surname><given-names>SB</given-names></name><name><surname>Waterhouse</surname><given-names>BJ</given-names></name><name><surname>Colquhoun</surname><given-names>D</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name></person-group><article-title>Improved persistence with non-vitamin-K oral anticoagulants
compared with warfarin in patients with atrial fibrillation: recent
Australian experience</article-title><source>Curr Med Res Opin</source><year>2016</year><month>11</month><volume>32</volume><issue>11</issue><fpage>1857</fpage><lpage>1861</lpage><pub-id pub-id-type="doi">10.1080/03007995.2016.1218325</pub-id><pub-id pub-id-type="pmid">27463735</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stirratt</surname><given-names>MJ</given-names></name><name><surname>Dunbar-Jacob</surname><given-names>J</given-names></name><name><surname>Crane</surname><given-names>HM</given-names></name><name><surname>Simoni</surname><given-names>JM</given-names></name><name><surname>Czajkowski</surname><given-names>S</given-names></name><name><surname>Hilliard</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Self-report measures of medication adherence behavior:
recommendations on optimal use</article-title><source>Transl Behav Med</source><year>2015</year><month>12</month><volume>5</volume><issue>4</issue><fpage>470</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1007/s13142-015-0315-2</pub-id><pub-id pub-id-type="pmid">26622919</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magnani</surname><given-names>JW</given-names></name><name><surname>Norby</surname><given-names>FL</given-names></name><name><surname>Agarwal</surname><given-names>SK</given-names></name><name><surname>Soliman</surname><given-names>EZ</given-names></name><name><surname>Chen</surname><given-names>LY</given-names></name><name><surname>Loehr</surname><given-names>LR</given-names></name><etal/></person-group><article-title>Racial differences in atrial fibrillation-related cardiovascular
disease and mortality: The Atherosclerosis Risk in Communities (ARIC)
study</article-title><source>JAMA Cardiol</source><year>2016</year><month>7</month><day>01</day><volume>1</volume><issue>4</issue><fpage>433</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1001/jamacardio.2016.1025</pub-id><pub-id pub-id-type="pmid">27438320</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Screenshots of the relational agent: (a) symptoms menu and (b) an emphatic
gesture.</p></caption><graphic xlink:href="nihms927354f1"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Summary of relational agent domain content.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1">Domain</th><th valign="middle" align="left" rowspan="1" colspan="1">Module content</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Education</td><td valign="top" align="left" rowspan="1" colspan="1">Causes of AF<xref rid="TFN1" ref-type="table-fn">a</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">AF treatment strategies</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Stroke prevention in AF</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">AliveCor Kardia use, troubleshooting</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Symptoms</td><td valign="top" align="left" rowspan="1" colspan="1">Overview of common symptoms</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Chest pain and chest pressure</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Heart racing or palpitations</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Dyspnea and shortness of breath</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Fatigue</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Adherence</td><td valign="top" align="left" rowspan="1" colspan="1">Overview of adherence</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Adherence to medications</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Adherence barriers</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Strategies to address barriers</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Patient activation</td><td valign="top" align="left" rowspan="1" colspan="1">Goals for self-management</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Preparing for the medical encounter</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>a</label><p>AF: atrial fibrillation.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Descriptive characteristics of the pilot cohort (N=31).</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1">Characteristics</th><th valign="middle" align="left" rowspan="1" colspan="1">Cohort (N=31)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age in years, mean (SD)</td><td valign="top" align="left" rowspan="1" colspan="1">68 (11)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Women, n (%)</td><td valign="top" align="left" rowspan="1" colspan="1">12 (39)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">White race, n (%)</td><td valign="top" align="left" rowspan="1" colspan="1">29 (94)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Education, &#x0003c;College, n
(%)</td><td valign="top" align="left" rowspan="1" colspan="1">21 (68)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Annual income, &#x0003c;US $35,000, n
(%)</td><td valign="top" align="left" rowspan="1" colspan="1">12 (39)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">S-TOFHLA<xref rid="TFN2" ref-type="table-fn">a</xref>&#x02264;23, n (%)</td><td valign="top" align="left" rowspan="1" colspan="1">7 (23)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BMI<xref rid="TFN3" ref-type="table-fn">b</xref>, kg/m, mean (SD)</td><td valign="top" align="left" rowspan="1" colspan="1">30.8 (8.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Current smoker, n (%)</td><td valign="top" align="left" rowspan="1" colspan="1">5 (16)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hypertension, n (%)</td><td valign="top" align="left" rowspan="1" colspan="1">21 (68)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Diabetes, n (%)</td><td valign="top" align="left" rowspan="1" colspan="1">4 (13)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Prevalent CVD<xref rid="TFN4" ref-type="table-fn">c</xref>, n (%)</td><td valign="top" align="left" rowspan="1" colspan="1">4 (13)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Prevalent heart failure, n (%)</td><td valign="top" align="left" rowspan="1" colspan="1">7 (23)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Prior stroke or TIA<xref rid="TFN5" ref-type="table-fn">d</xref>, n (%)</td><td valign="top" align="left" rowspan="1" colspan="1">5 (16)</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><label>a</label><p>S-TOFHLA: Short-Test of Functional Health Literacy in Adults.</p></fn><fn id="TFN3"><label>b</label><p>BMI: body mass index.</p></fn><fn id="TFN4"><label>c</label><p>CVD: cardiovascular disease.</p></fn><fn id="TFN5"><label>d</label><p>TIA: transient ischemic attack.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Selected assessments of the pilot cohort at baseline and 30 days.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1">Assessments</th><th valign="middle" align="left" rowspan="1" colspan="1">Baseline</th><th valign="middle" align="left" rowspan="1" colspan="1">30 days</th><th valign="middle" align="left" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">AFEQT<xref rid="TFN6" ref-type="table-fn">a</xref>, global score</td><td valign="top" align="left" rowspan="1" colspan="1">64.5 (22.9)</td><td valign="top" align="left" rowspan="1" colspan="1">76.3 (19.4)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.01</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>AFEQT domains</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Symptoms</td><td valign="top" align="left" rowspan="1" colspan="1">74.6 (24.1)</td><td valign="top" align="left" rowspan="1" colspan="1">80.7 (21.4)</td><td valign="top" align="left" rowspan="1" colspan="1">.07</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Daily activities</td><td valign="top" align="left" rowspan="1" colspan="1">56.0 (27.8)</td><td valign="top" align="left" rowspan="1" colspan="1">65.2 (26.1)</td><td valign="top" align="left" rowspan="1" colspan="1">.01</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Treatment concerns</td><td valign="top" align="left" rowspan="1" colspan="1">66.7 (26.2)</td><td valign="top" align="left" rowspan="1" colspan="1">74.6 (22.6)</td><td valign="top" align="left" rowspan="1" colspan="1">.08</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Treatment satisfaction</td><td valign="top" align="left" rowspan="1" colspan="1">71.2 (25.4)</td><td valign="top" align="left" rowspan="1" colspan="1">72.9 (27.6)</td><td valign="top" align="left" rowspan="1" colspan="1">.71</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MMAS<xref rid="TFN7" ref-type="table-fn">b</xref></td><td valign="top" align="left" rowspan="1" colspan="1">7.3 (0.9)</td><td valign="top" align="left" rowspan="1" colspan="1">7.7 (0.5)</td><td valign="top" align="left" rowspan="1" colspan="1">.01</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PAM<xref rid="TFN8" ref-type="table-fn">c</xref></td><td valign="top" align="left" rowspan="1" colspan="1">3.0 (0.8)</td><td valign="top" align="left" rowspan="1" colspan="1">3.4 (0.7)</td><td valign="top" align="left" rowspan="1" colspan="1">.33</td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><label>a</label><p>AFEQT: Atrial Fibrillation Effect on Quality of life.</p></fn><fn id="TFN7"><label>b</label><p>MMAS: Morisky 8-item Medication Adherence Scale.</p></fn><fn id="TFN8"><label>c</label><p>PAM: Patient Activation Measure.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Relational agent acceptability assessment using a Likert-score ranging from 1 to
7.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1">Item</th><th valign="middle" align="left" rowspan="1" colspan="1">Description of range</th><th valign="middle" align="left" rowspan="1" colspan="1">Median (range)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">How satisfied were you with Tanya?</td><td valign="top" align="left" rowspan="1" colspan="1">1=Not at all; 7=Very
satisfied</td><td valign="top" align="left" rowspan="1" colspan="1">5(1&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">How easy was talking to Tanya?</td><td valign="top" align="left" rowspan="1" colspan="1">1=Easy; 7=Difficult</td><td valign="top" align="left" rowspan="1" colspan="1">1 (1&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">How much would you like to continue working
with Tanya?</td><td valign="top" align="left" rowspan="1" colspan="1">1=Not at all; 7=Very much</td><td valign="top" align="left" rowspan="1" colspan="1">5(1&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">How much do you like Tanya?</td><td valign="top" align="left" rowspan="1" colspan="1">1=Not at all; 7=Very much</td><td valign="top" align="left" rowspan="1" colspan="1">5(1&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">How would you characterize your relationship
with Tanya?</td><td valign="top" align="left" rowspan="1" colspan="1">1=Complete stranger; 7=Close
friend</td><td valign="top" align="left" rowspan="1" colspan="1">4(1&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">How much do you trust Tanya?</td><td valign="top" align="left" rowspan="1" colspan="1">1=Not at all; 7=Very much</td><td valign="top" align="left" rowspan="1" colspan="1">5 (3&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">How much do you feel that Tanya cares about
you?</td><td valign="top" align="left" rowspan="1" colspan="1">1=Not at all; 7=Very much</td><td valign="top" align="left" rowspan="1" colspan="1">5 (3&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">How much do you feel that you and Tanya
understand each other?</td><td valign="top" align="left" rowspan="1" colspan="1">1=Not at all; 7=Very much</td><td valign="top" align="left" rowspan="1" colspan="1">5(1&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">I feel uncomfortable with Tanya.</td><td valign="top" align="left" rowspan="1" colspan="1">1=Disagree completely; 7=Agree
completely</td><td valign="top" align="left" rowspan="1" colspan="1">1 (1&#x02013;5)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Tanya and I understand each other.</td><td valign="top" align="left" rowspan="1" colspan="1">1=Disagree completely; 7=Agree
completely</td><td valign="top" align="left" rowspan="1" colspan="1">4(1&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">I believe Tanya likes me.</td><td valign="top" align="left" rowspan="1" colspan="1">1=Disagree completely; 7=Agree
completely</td><td valign="top" align="left" rowspan="1" colspan="1">4(1&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">I believe Tanya is genuinely concerned about
my welfare.</td><td valign="top" align="left" rowspan="1" colspan="1">1=Disagree completely; 7=Agree
completely</td><td valign="top" align="left" rowspan="1" colspan="1">5(1&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Tanya and I respect each other.</td><td valign="top" align="left" rowspan="1" colspan="1">1=Disagree completely; 7=Agree
completely</td><td valign="top" align="left" rowspan="1" colspan="1">5(1&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">I feel that Tanya is not totally honest about
her feelings toward me.</td><td valign="top" align="left" rowspan="1" colspan="1">1=Disagree completely; 7=Agree
completely</td><td valign="top" align="left" rowspan="1" colspan="1">1 (1&#x02013;5)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">I am confident in Tanya&#x02019;s ability to
help me.</td><td valign="top" align="left" rowspan="1" colspan="1">1=Disagree completely; 7=Agree
completely</td><td valign="top" align="left" rowspan="1" colspan="1">5 (3&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">I feel that Tanya appreciates me.</td><td valign="top" align="left" rowspan="1" colspan="1">1=Disagree completely; 7=Agree
completely</td><td valign="top" align="left" rowspan="1" colspan="1">4(1&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Tanya and I trust one another.</td><td valign="top" align="left" rowspan="1" colspan="1">1=Disagree completely; 7=Agree
completely</td><td valign="top" align="left" rowspan="1" colspan="1">4(1&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">My relationship with Tanya is very important
to me.</td><td valign="top" align="left" rowspan="1" colspan="1">1=Disagree completely; 7=Agree
completely</td><td valign="top" align="left" rowspan="1" colspan="1">4(1&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">I have the feeling that if I say or do the
wrong things, Tanya will stop working with me.</td><td valign="top" align="left" rowspan="1" colspan="1">1=Disagree completely; 7=Agree
completely</td><td valign="top" align="left" rowspan="1" colspan="1">4(1&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">I feel Tanya cares about me even when I do
things she does not approve of.</td><td valign="top" align="left" rowspan="1" colspan="1">1=Disagree completely; 7=Agree
completely</td><td valign="top" align="left" rowspan="1" colspan="1">1 (1&#x02013;4)</td></tr></tbody></table></table-wrap></floats-group></article>